Aberdare Ventures is a San Francisco-based venture capital firm established in 1999, specializing in early-stage investments within the healthcare sector. The firm focuses on companies that leverage biological, engineering, and information technologies to transform healthcare. With a committed capital base exceeding $400 million, Aberdare Ventures has partnered with numerous early-stage companies, including Ironwood, Pharmion, Clovis Oncology, and MC10, many of which have achieved valuations exceeding $1 billion.

The firm's investment philosophy centers on a limited number of entrepreneurial teams, aiming to increase the probability of success for portfolio companies and generate greater returns for investors.